Probiotic Lactobacillus rhamnosus mitigates PBC-like features in Mcpip1-deficient mice via modulation of gut-liver crosstalk
Probiotic intervention with Lbr represents a feasible strategy to attenuate fibrotic progression in a mouse model of autoimmune cholestatic disease by modulation of the gut-microbiome-immune crosstalk.
Authors
- Marcin Krawczyk (ORCID: https://orcid.org/0000-0002-0113-0777)
- Jacqueline Rehner (ORCID: https://orcid.org/0000-0003-1335-4898)
- Magdalena Pilarczyk-Żurek
- Jolanta Jura (ORCID: https://orcid.org/0000-0002-0816-3475)
- Katarzyna Trzos (ORCID: https://orcid.org/0009-0004-4544-8658)
- Anastasiia Koval
- Guillem Ylla (ORCID: https://orcid.org/0000-0003-4540-0131)
- Jerzy Kotlinowski (ORCID: https://orcid.org/0000-0002-3133-3364)
- Gabriela Machaj (ORCID: https://orcid.org/0000-0003-3648-0475)
- Joanna Ewa Koziel
- Marcin Bednarek (ORCID: https://orcid.org/0000-0003-3882-4542)
- S.C. Becker
- Tomasz Hutsch
- Szymon Surma
- Md Mobashir Rahman
- Bahtiyar Yilmaz
- Leidy-Alejandra G Molano
- Maximilian Olaf Förster
- Danuta Śmierciak
- Andreas Keller
Institutions
- University of Bern (CH)
- Jagiellonian University (PL)
- Bern University of Applied Sciences (CH)
- Warsaw University of Life Sciences (PL)
- Medical University of Warsaw (PL)
- University Hospital of Bern (CH)
- Institute of Medical Microbiology and Hygiene (DE)
- Helmholtz Institute for Pharmaceutical Research Saarland (DE)
- Saarland University (DE)
Publication Details
- Journal
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1016/j.bbadis.2026.168216
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00